levodopa has been researched along with Glial Cell Tumors in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Bomanji, J; Ferrazzoli, V; Fraioli, F; Hyare, H; Lyasheva, M; Mankad, K; Mehdi, E; Militano, V; Novruzov, F; Samandouras, G; Shankar, A; Solda, F; Zaccagna, F | 1 |
Barth, RF; Chandra, S; Haider, SA; Huo, T; Kabalka, GW; Shaikh, AL; Yang, W | 1 |
Bozzali, M; Cametti, C; Capuani, S; Colasanti, M; D'Amore, E; Gili, T; Lazzarino, G; Maraviglia, B; Pastore, FS; Porcari, P; Russo, S; Venturini, G | 1 |
Bozzali, M; Cametti, C; Capuani, S; D'Amore, E; Gili, T; Lazzarino, G; Maraviglia, B; Muolo, M; Pastore, FS; Porcari, P; Russo, S | 1 |
Chemaitilly, W; Hua, C; Lukose, RC; Merchant, TE; Wu, S | 1 |
Bourgeat, P; Coulthard, A; Crozier, S; Dowson, N; Fay, M; Gal, Y; Rose, S; Salvado, O; Thomas, P | 1 |
Mazzio, E; Soliman, KF; Soliman, MK | 1 |
Harjula, A; Huotari, M; Lampela, P; Männistö, PT; Oinonen, L; Raasmaja, A; Ustav, M; Ylä-Herttuala, S | 1 |
Appel, SH; Jankovic, J; Le, W; Rowe, DB; Xie, W; Zou, L | 1 |
1 trial(s) available for levodopa and Glial Cell Tumors
Article | Year |
---|---|
Predicting the probability of abnormal stimulated growth hormone response in children after radiotherapy for brain tumors.
Topics: Adolescent; Arginine; Biomarkers; Brain Neoplasms; Child; Child, Preschool; Craniopharyngioma; Ependymoma; Feasibility Studies; Female; Glioma; Human Growth Hormone; Humans; Hypothalamus; Infant; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Levodopa; Logistic Models; Male; Models, Biological; Predictive Value of Tests; Probability; Prospective Studies; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; ROC Curve; Sensitivity and Specificity | 2012 |
8 other study(ies) available for levodopa and Glial Cell Tumors
Article | Year |
---|---|
The use of multiparametric 18F-fluoro-L-3,4-dihydroxy-phenylalanine PET/MRI in post-therapy assessment of patients with gliomas.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Female; Fluorine Radioisotopes; Glioma; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Precision Medicine; Tumor Burden; Young Adult | 2020 |
Effects of l-DOPA pre-loading on the uptake of boronophenylalanine using the F98 glioma and B16 melanoma models.
Topics: Animals; Boron Compounds; Brain Neoplasms; Drug Synergism; Female; Glioma; Levodopa; Melanoma; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Organ Specificity; Phenylalanine; Premedication; Tissue Distribution; Treatment Outcome | 2014 |
L-DOPA preloading increases the uptake of borophenylalanine in C6 glioma rat model: a new strategy to improve BNCT efficacy.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Brain; Brain Neoplasms; Dopamine Agents; Glioma; Levodopa; Male; Phenylalanine; Rats | 2008 |
Boronophenylalanine uptake in C6 glioma model is dramatically increased by L-DOPA preloading.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Cell Line, Tumor; Glioma; In Vitro Techniques; Levodopa; Magnetic Resonance Imaging; Male; Phenylalanine; Radiation-Sensitizing Agents; Rats; Rats, Wistar | 2009 |
Correlation of MRI-derived apparent diffusion coefficients in newly diagnosed gliomas with [18F]-fluoro-L-dopa PET: what are we really measuring with minimum ADC?
Topics: Aged; Aged, 80 and over; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Dopamine Agents; Female; Fluorodeoxyglucose F18; Glioma; Humans; Levodopa; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals | 2013 |
Levodopa modulating effects of inducible nitric oxide synthase and reactive oxygen species in glioma cells.
Topics: Adrenergic beta-2 Receptor Antagonists; Animals; Antioxidants; Antiparkinson Agents; Blotting, Western; Brain Neoplasms; Catechols; Cell Survival; Free Radicals; Glioma; Hydrogen Peroxide; Interferon-gamma; Levodopa; Lipopolysaccharides; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Oxidants; Oxidation-Reduction; Rats; Reactive Oxygen Species; Receptors, Dopamine D1; Recombinant Proteins; Superoxide Dismutase; Superoxides | 2002 |
Production of functional recombinant tyrosine hydroxylase by the BPV-1 expression plasmids in the cell cultures.
Topics: Animals; Astrocytes; Bovine papillomavirus 1; Cells, Cultured; Central Nervous System Neoplasms; Dopamine; Fibroblasts; Glioma; Humans; Levodopa; Plasmids; Protein Engineering; Rats; Recombinant Proteins; RNA, Messenger; Transfection; Tyrosine 3-Monooxygenase | 2003 |
Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity.
Topics: Animals; Benzothiazoles; Cell Line; Cell Survival; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Glioma; Hybrid Cells; Kinetics; Levodopa; Neuroblastoma; Neuroprotective Agents; Pramipexole; Thiazoles | 1999 |